• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hemin ameliorates influenza pneumonia by attenuating lung injury and regulating the immune response

tetano

Editor, Senior Moderator
Int J Antimicrob Agents. 2016 Nov 16. pii: S0924-8579(16)30337-5. doi: 10.1016/j.ijantimicag.2016.09.030. [Epub ahead of print]
[h=1]Hemin ameliorates influenza pneumonia by attenuating lung injury and regulating the immune response.[/h] Wang C[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Han L[SUP]1[/SUP], Guo L[SUP]1[/SUP], Zhong H[SUP]2[/SUP], Wang J[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The anti-influenza activity of hemin, an inducer, activator and the substrate of heme oxygenase-1 (HO-1), was examined both in vitro and in vivo. The human lung carcinoma cell line A549 was used to evaluate the in vitro effect of hemin on influenza A virus (IAV) replication. A mouse model was used to examine the in vivo activity of hemin. Observation indexes included survival rate and body weight of mice, virus load and pathological examination of the lungs, and characterization of the systemic and local immune responses. The results showed that hemin could induce HO-1 expression in A549 cells and inhibit IAV replication in vitro. The in vivo results showed that injection of hemin could protect mice from death and body weight loss caused by IAV infection. Hemin was administered both at initial and progressive stages of influenza pneumonia (1 day and 4 days after virus infection, respectively) and showed significant anti-influenza activity under both conditions. However, the results showed that although hemin could induce HO-1 expression in vivo, it could not inhibit IAV replication in vivo. Pathological examination showed that hemin significantly attenuated lung tissue injury caused by IAV. Further study showed that hemin could regulate the immune response to IAV infection by reducing lymphocytopenia and local inflammatory cytokine increases caused by IAV infection. This study shows that hemin has the potential for the treatment of IAV infection and its effect may be due to attenuation of lung injury and regulation of the immune response.
Copyright © 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.


[h=4]KEYWORDS:[/h] Heme oxygenase-1; Hemin; Immune regulation; Influenza virus; Lung injury

PMID: 27884416 DOI: 10.1016/j.ijantimicag.2016.09.030
[PubMed - as supplied by publisher]
 
Back
Top Bottom